ReVance Therapeutics, Inc. To Add Angus C. Russell As Chairman To Its Board Of Directors
Published: Mar 05, 2014
NEWARK, Calif., March 5, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC), a specialty biopharmaceutical company which develops botulinum toxin products for use in aesthetic and therapeutic indications, today announced that Angus C. Russell has been appointed as Chairman to its Board of Directors, effective immediately.
Help employers find you! Check out all the jobs and post your resume.